BusinessAthersys Reports Alignment of Key Regulators for Pivotal Registration Study in StrokeBy Nasdaq OMXAug 7, 2017, 10:00 AM UTC
BusinessAthersys Announces Acceptance by PMDA of Clinical Trial Notification in Japan for Treatment of Ischemic Stroke With MultiStem®By Nasdaq OMXSep 12, 2016, 10:30 AM UTC
